We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

ENS:NYSEEnerSys Analysis

Data as of 2026-03-31 - not real-time

$171.94

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

EnerSys trades at $171.94, roughly 25% above its DCF‑derived fair value of $136.68, suggesting the market may be pricing in near‑term optimism. The stock sits just above its 20‑day SMA (166.0) and essentially matches the 50‑day SMA (171.5), while the MACD remains bullish with a histogram of 0.80, indicating continued upward momentum. Momentum indicators are neutral‑to‑positive, with an RSI of 53 and a beta of 1.31 pointing to slightly higher volatility than the broader market (38% 30‑day volatility). Fundamentals show modest revenue growth (1.4%) but a strong earnings trajectory, as forward EPS of $11.76 represents a ~46% uplift versus trailing EPS of $8.06, and the forward P/E of 14.6 is well‑below the industry average of 28.4. The dividend yield of 0.63% is supported by a low payout ratio of 12.5%, indicating sustainability, and free cash flow of $410 M underpins the balance sheet despite a debt‑to‑equity of 62%. Recent material news – an Investor Day outlining the “EnerGize” strategy, a strategic manufacturing restructuring in Mexico, and highlighted growth in data‑center batteries, lithium trials, and a South Carolina defense pivot – could act as catalysts for renewed investor interest.
The technical picture is mixed: while the price is near the upper end of its recent range (resistance $180.84) and the trend is neutral, the stable volume and bullish MACD suggest short‑term upside potential. Valuation metrics imply the stock is currently overvalued relative to intrinsic estimates, yet the forward earnings multiple and sector‑specific growth themes (industrial energy storage, EV charging) provide a blend of value and growth appeal. With a sustainable dividend, solid cash generation, and upcoming strategic disclosures, the medium‑term outlook leans toward a buy, whereas the long‑term view remains cautious, favoring a hold stance pending clearer execution of the outlined growth initiatives.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bullish MACD but neutral price trend
  • Proximity to resistance at $180.84
  • Stable trading volume

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Forward earnings multiple (14.6) below industry average
  • Strategic initiatives highlighted in Investor Day and manufacturing restructuring
  • Growth exposure in data‑center storage and lithium battery trials

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Sustainable dividend with low payout ratio
  • Modest revenue growth and high debt‑to‑equity
  • Potential valuation compression if DCF fair value remains unchanged

Key Metrics & Analysis

Financial Health

Revenue Growth1.40%
Profit Margin8.37%
P/E Ratio21.3
ROE16.71%
ROA7.40%
Debt/Equity62.24
P/B Ratio3.3
Op. Cash Flow$538.8M
Free Cash Flow$409.9M
Industry P/E28.4

Technical Analysis

TrendNeutral
RSI53.7
Support$150.75
Resistance$180.84
MA 20$166.01
MA 50$171.48
MA 200$130.53
MACDBullish
VolumeStable
Fear & Greed Index74.8

Valuation

Fair Value$136.68
Target Price$189.09
Upside/Downside9.98%
GradeOvervalued
TypeBlend
Dividend Yield0.63%

Risk Assessment

Beta1.31
Volatility38.30%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.